
Upgrade
Turnaround Complete: Teva Regains Investment-Grade Rating From All Agencies
S&P upgraded Teva’s long-term credit rating from BB+ to BBB- with a stable outlook • The move completes the company’s return to investment grade at all three major rating agencies after several years • The company says the upgrade reflects growth in innovative medicines and stabilization in generics